These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 19532127)

  • 1. Low Mannan-binding lectin serum levels are associated with complicated Crohn's disease and reactivity to oligomannan (ASCA).
    Schoepfer AM; Flogerzi B; Seibold-Schmid B; Schaffer T; Kun JF; Pittet V; Mueller S; Seibold F
    Am J Gastroenterol; 2009 Oct; 104(10):2508-16. PubMed ID: 19532127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mannan-binding lectin deficiency results in unusual antibody production and excessive experimental colitis in response to mannose-expressing mild gut pathogens.
    Müller S; Schaffer T; Flogerzi B; Seibold-Schmid B; Schnider J; Takahashi K; Darfeuille-Michaud A; Vazeille E; Schoepfer AM; Seibold F
    Gut; 2010 Nov; 59(11):1493-500. PubMed ID: 20682699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mannose-binding lectin deficiency is not associated with anti-Saccharomyces cerevisiae antibody in Korean Crohn's disease patients.
    Kim YS; Kim YH; Ye BD; Park DW; Kim JW; Han DS
    Clin Chim Acta; 2014 Feb; 429():206-11. PubMed ID: 24374090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants of the mannan-binding lectin are associated with immune reactivity to mannans in Crohn's disease.
    Seibold F; Konrad A; Flogerzi B; Seibold-Schmid B; Arni S; Jüliger S; Kun JF
    Gastroenterology; 2004 Oct; 127(4):1076-84. PubMed ID: 15480986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease.
    Gologan S; Iacob R; Preda C; Vadan R; Cotruta B; Catuneanu AM; Iacob S; Constantinescu I; Gheorghe L; Iobagiu S; Gheorghe C; Diculescu M
    J Gastrointestin Liver Dis; 2012 Mar; 21(1):39-44. PubMed ID: 22457858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease.
    Sendid B; Quinton JF; Charrier G; Goulet O; Cortot A; Grandbastien B; Poulain D; Colombel JF
    Am J Gastroenterol; 1998 Aug; 93(8):1306-10. PubMed ID: 9707056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased titers of anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients with reduced H-ficolin levels but normal MASP-2 activity.
    Schaffer T; Flogerzi B; Schoepfer AM; Seibold F; Müller S
    J Crohns Colitis; 2013 Feb; 7(1):e1-10. PubMed ID: 22445443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of antisynthetic mannoside antibodies (ASigmaMA) reveals heterogeneity in the ASCA response of Crohn's disease patients and contributes to differential diagnosis, stratification, and prediction.
    Vandewalle-El Khoury P; Colombel JF; Joossens S; Standaert-Vitse A; Collot M; Halfvarson J; Ayadi A; Landers CJ; Vermeire S; Rutgeerts P; Targan SR; Chamaillard M; Mallet JM; Sendid B; Poulain D
    Am J Gastroenterol; 2008 Apr; 103(4):949-57. PubMed ID: 18047546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of deficiency for mannan-binding lectin with anti-mannan antibodies in Crohn's disease: a family study.
    Seibold F; Boldt AB; Seibold-Schmid B; Schoepfer AM; Flogerzi B; Müller S; Kun JF
    Inflamm Bowel Dis; 2007 Sep; 13(9):1077-82. PubMed ID: 17480019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial expression of anti-Saccharomyces cerevisiae Mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study.
    Annese V; Andreoli A; Andriulli A; Dinca R; Gionchetti P; Latiano A; Lombardi G; Piepoli A; Poulain D; Sendid B; Colombel JF
    Am J Gastroenterol; 2001 Aug; 96(8):2407-12. PubMed ID: 11513182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Saccharomyces cerevisiae antibodies: a stable marker for Crohn's disease during steroid and 5-aminosalicylic acid treatment.
    Teml A; Kratzer V; Schneider B; Lochs H; Norman GL; Gangl A; Vogelsang H; Reinisch W
    Am J Gastroenterol; 2003 Oct; 98(10):2226-31. PubMed ID: 14572572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of anti-sacharomices cerevisiae antibodies (ASCA) in patients with inflammatory bowel diseases in Romania.
    Preda CM; Diculescu M; Mirea V; Marica C; Vermeire S; Rutgeerts P; Oproiu A
    Rom J Gastroenterol; 2005 Mar; 14(1):23-6. PubMed ID: 15800689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
    Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
    Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
    Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mannose-binding lectin level and deficiency is not associated with inflammatory bowel diseases, disease phenotype, serology profile, and NOD2/CARD15 genotype in a large Hungarian cohort.
    Papp M; Lakatos PL; Harsfalvi J; Farkas G; Palatka K; Udvardy M; Molnar T; Farkas K; Nagy F; Veres G; Lakatos L; Kovacs A; Dinya T; Kocsis AK; Papp J; ; Altorjay I
    Hum Immunol; 2010 Apr; 71(4):407-13. PubMed ID: 20079790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease.
    Koutroubakis IE; Petinaki E; Mouzas IA; Vlachonikolis IG; Anagnostopoulou E; Castanas E; Maniatis AN; Kouroumalis EA
    Am J Gastroenterol; 2001 Feb; 96(2):449-54. PubMed ID: 11232689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethnic and socio-cultural specificities in Tunisia have no impact on the prevalence of anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients, their relatives or associated clinical factors.
    Hadrich I; Vandewalle P; Cheikhrouhou F; Makni F; Krichen MS; Sendid B; Standaert-Vitse A; Ayadi A; Poulain D
    Scand J Gastroenterol; 2007 Jun; 42(6):717-25. PubMed ID: 17505994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype.
    Arnott ID; Landers CJ; Nimmo EJ; Drummond HE; Smith BK; Targan SR; Satsangi J
    Am J Gastroenterol; 2004 Dec; 99(12):2376-84. PubMed ID: 15571586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of anti-Saccharomyces cerevisiae antibody (ASCA) in Korean patients with Crohn's disease and its relationship to the disease clinical course.
    Kim BC; Park S; Han J; Kim JH; Kim TI; Kim WH
    Dig Liver Dis; 2007 Jul; 39(7):610-6. PubMed ID: 17531556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CARD15 polymorphisms are associated with anti-Saccharomyces cerevisiae antibodies in caucasian Crohn's disease patients.
    Cruyssen BV; Peeters H; Hoffman IE; Laukens D; Coucke P; Marichal D; Cuvelier C; Remaut E; Veys EM; Mielants H; De Vos M; De Keyser F
    Clin Exp Immunol; 2005 May; 140(2):354-9. PubMed ID: 15807862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.